Using the latest TTM figures, AMGEN shows a gross margin of 69.5%, an operating margin of 30%, an EBITDA margin of 46.3%, and a net margin of 23%. Operating margin had the largest improvement, increasing by 6.5 percentage points, while the other available margins also improved.
Over the last 3 years, AMGEN recorded average margins of 66.17% gross, 24.83% operating, 45.13% EBITDA, and 18.41% net. The current gross, operating, EBITDA, and net margins are all above their three-year averages.
All available margins expanded year over year, led by operating margin with an increase of 6.5 percentage points.
Across the last 3 years, AMGEN's gross margin came to 66.17%. The current gross margin stands at 69.5%, 3.3 percentage points above its three-year average. Gross margin was highest at 73.6% in Sep 2023 and lowest at 60.5% in Sep 2024.
Across the last 3 years, AMGEN's operating margin averaged 24.83%. Against its three-year average, AMGEN's operating margin is currently 30%, 5.2 percentage points above its three-year average. Operating margin was highest at 33% in Sep 2023 and lowest at 19.1% in Sep 2024.
Over the last 3 years, AMGEN had an average EBITDA margin of 45.13%. Against its three-year average, AMGEN's EBITDA margin is currently 46.3%, 1.2 percentage points above its three-year average. Looking back over the last 3 years, AMGEN's EBITDA margin reached 55.2% at its highest point in Sep 2023 and 38.2% at its lowest in Jun 2024.
Over the last 3 years, AMGEN's net margin averaged 18.41%. The current net margin of 23% is 4.6 percentage points above its three-year average. During this period, net margin reached a high of 28.2% in Sep 2023 and a low of 10.1% in Jun 2024.
With a gross margin of 69.5%, AMGN stands higher than the Healthcare sector and the industry average but lower than its peers average. But when looking at the Healthcare sector average of 68.5%, AMGEN's gross margin is only 1.5% higher.
For the period ending Jun 30, 2026, AMGN recorded a gross margin of 69.5%.
For the period ending Jun 30, 2026, AMGN recorded an operating margin of 30%.
The current EBITDA margin for AMGN is 46.3% as of Jun 30, 2026.
For the period ending Jun 30, 2026, AMGN recorded a net margin of 23%.
Over the last 3 years, AMGEN's margins averaged 66.2% gross, 24.8% operating, 45.1% EBITDA, and 18.4% net.
AMGEN's highest recorded margins during the past 5 years were 75.8% gross in Sep 2022, 36.6% operating in Sep 2022, 55.7% EBITDA in Jun 2023, and 30.2% net in Mar 2023.
Over this 5-year history, AMGEN's margins fell as low as 60.5% gross in Sep 2024, 19.1% operating in Sep 2024, 38.2% EBITDA in Jun 2024, and 10.1% net in Jun 2024.